[1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, et al. (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334(8): 494-500.10.1056/NEJM1996022233408038559202]Search in Google Scholar
[2. McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, et al. (2007) Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 189(4): 904-912.10.2214/AJR.07.202417885064]Search in Google Scholar
[3. Gatla N, Annapureddy N, Sequeira W, Jolly M (2013) Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus. J Clin Rheumatol 19(6): 334-340.10.1097/RHU.0b013e3182a21ffd23965484]Open DOISearch in Google Scholar
[4. Kur JK, Esdaile JM (2006) Posterior reversible encephalopathy syndrome-an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol 33(11): 2178-2183.]Search in Google Scholar
[5. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 29(6): 1036-1042.10.3174/ajnr.A0928811882818356474]Open DOISearch in Google Scholar
[6. Bartynski WS (2008) Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29(6): 1043-1049.10.3174/ajnr.A0929811881318403560]Open DOISearch in Google Scholar
[7. Chien-Chih Lai, Wei-Sheng Chen, Yu-Sheng Chang, Shu-Hung Wang, Chun-Jui et al. (2013) Clinical Features and Outcomes of Posterior Reversible Encephalopathy Syndrome in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research (Roboken) 65(11): 17661774.10.1002/acr.22047]Search in Google Scholar
[8. Fugate JE, Rabinstein AA (2015) Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 14(9): 914-925.10.1016/S1474-4422(15)00111-8]Search in Google Scholar
[9. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 21(7): 1199-1206.]Search in Google Scholar
[10. Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, (2010) Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 112(10): 886-889.10.1016/j.clineuro.2010.07.02320800343]Search in Google Scholar
[11. Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA (2007) Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69(9): 894-897.10.1212/01.wnl.0000269780.45472.1617724292]Search in Google Scholar
[12. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA (2008) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 65(2): 205-210.10.1001/archneurol.2007.4618268188]Search in Google Scholar
[13. Legriel S, Pico f, Azoulay E (2011) Understanding Posterior Reversible Encephalopathy Syndrome. Vincent JL (Ed.), Annual Update in Intensive Care and Emergency Medicine 2011: 631-653.10.1007/978-3-642-18081-1_56]Open DOISearch in Google Scholar
[14. Shaharir SS, Remli R, Marwan AA, Said MS, Kong NC (2013) Posterior reversible encephalopathy syndrome in systemic lupus erythematosus: pooled analysis of the literature reviews and report of six new cases. Lupus 22(5): 492-496.10.1177/096120331347830323435619]Open DOISearch in Google Scholar
[15. Schattner A, Al-Bewerat A. Levetiracetam (Keppra) (2016) Urinary retention and literature search. The Netherlands Journal of Medicine 74(8): 371.]Search in Google Scholar
[16. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, et al. (2008) Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 17(2):139-147.10.1177/096120330708540518250139]Open DOISearch in Google Scholar
[17. Gatla N, Annapureddy N, Sequeira W, Jolly M (2013) Posterior reversible encephalopathy syndrome in systemic lupus erythematosus. J Clin Rheumatol 19(6): 334-340.10.1097/RHU.0b013e3182a21ffd23965484]Open DOISearch in Google Scholar
[18. Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.Arch Neurol. 2008;65:205–21010.1001/archneurol.2007.4618268188]Search in Google Scholar
[19. Schattner A, Al-Bewera A, Levetiracetam (Keppra), urinary retention and literature search. The Ned J Med. 2016, 74: 371]Search in Google Scholar